3629 results for «386»
3629 results
Decision-making based on intracoronary imaging in CTO-PCI
17 May 2023 – From EuroPCR 2023
Join this session dedicated to "Advancing Percutaneous Coronary Intervention for Chronic Total Occlusion". Explore the latest advances, evidence-based practices and transformative techniques that leverage intracoronary imaging to improve decision-making in percutaneous coronary intervention for chronic total occlusion. Be inspired by leading experts and collaborate with other...
Tricuspid and pulmonary valves: the right heart in trouble
18 May 2023 – From EuroPCR 2023
Explore the intricacies of tricuspid and pulmonary valve disorders, as we delve into the challenges faced by the right heart in this session: discover the groundbreaking approach of triple percutaneous valvular therapy in patient with congenital heart disease, learn about innovative strategies for managing massive atrial...
Complex aortic iliac interventions
17 May 2023 – From EuroPCR 2023
Consult this session to find out more about common iliac CTO PTA via radial approach, transbrachial intervention of bilateral common iliac arteries, shifting of thrombus across the aortoiliac bifurcation during iliac stenting, and much more!
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.
Author
